Table 2.
Demographic and sampling characteristics of the population-based cross-sectional serosurvey participants by country
| Dhaka, Bangladesh (n=401) | Kathmandu, Nepal (n=353) | Kavrepalanchok, Nepal (n=481) | Aga Khan University Hospital, Karachi, Pakistan (n=294) | Kharadar General Hospital, Karachi, Pakistan (n=200) | Agogo, Ghana (n=79) | ||
|---|---|---|---|---|---|---|---|
| Age, years | 9·2 (4·9–14·0) | 12·0 (5·8–17·8) | 10·2 (5·1–15·7) | 10·0 (4·9–16·0) | 8·0 (4·9–13·7) | 6·0 (5·0–9·0) | |
| Age strata | |||||||
| <5 years | 101 (25·2%) | 73 (20·7%) | 113 (23·5%) | 75 (25·5%) | 51 (25·5%) | 18 (22·8%) | |
| 5–15 years | 256 (63·8%) | 169 (47·9%) | 249 (51·8%) | 143 (48·6%) | 118 (59·0%) | 59 (74·7%) | |
| 16–25 years | 44 (11·0%) | 111 (31·4%) | 119 (24·7%) | 76 (25·9%) | 31 (15·5%) | 2 (2·5%) | |
| Missing data | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sex | |||||||
| Male | 183 (45·6%) | 184 (52·1%) | 248 (51·6%) | 135 (45·9%) | 97 (48·5%) | 47 (59·5%) | |
| Female | 218 (54·4%) | 169 (47·9%) | 233 (48·4%) | 159 (54·1%) | 103 (51·5%) | 32 (40·5%) | |
| Missing data | 0 | 0 | 0 | 0 | 0 | 0 | |
| Vaccine status | |||||||
| Typhoid conjugate vaccine | 13 (3·2%) | 0 | 0 | 127 (43·2%) | 85 (42·5%) | 0 | |
| Other typhoid vaccine | 17 (4·2%) | 3 (0·8%) | 1 (0·2%) | 3 (1·0%) | 1 (0·5%) | 0 | |
| Not vaccinated | 371 (92·5%) | 348 (98·6%) | 480 (99·8%) | 164 (55·8%) | 114 (57·0%) | 79 (100%) | |
| Missing data | 0 | 2 (0·6%) | 0 | 0 | 0 | 0 | |
Data are median (IQR) or n (%)